Published in Arch Phys Med Rehabil on February 01, 2005
Effects of optic flow speed and lateral flow asymmetry on locomotion in younger and older adults: a virtual reality study. J Gerontol B Psychol Sci Soc Sci (2009) 0.91
Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson's disease. J Biomed Sci (2010) 0.90
Quadrupedal coordination of bipedal gait: implications for movement disorders. J Neurol (2011) 0.86
Interlimb coordination is impaired during walking in persons with Parkinson's disease. Clin Biomech (Bristol, Avon) (2012) 0.86
Lower-limb joint coordination pattern in obese subjects. Biomed Res Int (2012) 0.83
Energy cost of spontaneous walking in Parkinson's disease patients. Neurol Sci (2011) 0.81
Dynamic control of posture across locomotor tasks. Mov Disord (2013) 0.81
Obstacle stepping in patients with Parkinson's disease. Complexity does influence performance. J Neurol (2009) 0.80
Does Nordic Walking restore the temporal organization of gait variability in Parkinson's disease? J Neuroeng Rehabil (2017) 0.79
Neural Control of Walking in People with Parkinsonism. Physiology (Bethesda) (2016) 0.78
Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein. Appl Sci (Basel) (2014) 0.78
Effects of augmented exercise therapy time after stroke: a meta-analysis. Stroke (2004) 3.83
Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol (2004) 3.79
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol (2007) 3.25
Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 2.23
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging (2010) 2.09
Gait characteristics of elderly people with a history of falls: a dynamic approach. Phys Ther (2006) 1.75
Efficacy of a physical therapy program in patients with Parkinson's disease: a randomized controlled trial. Arch Phys Med Rehabil (2005) 1.52
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database. Eur J Nucl Med Mol Imaging (2012) 1.47
Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. J Neurol Neurosurg Psychiatry (2012) 1.47
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging (2009) 1.45
Cerebral impairment in chronic solvent-induced encephalopathy. Ann Neurol (2008) 1.45
Arm constraint and walking in healthy adults. Gait Posture (2006) 1.42
Effect of body-scaled information on reaching in children with hemiplegic cerebral palsy: a pilot study. Pediatr Phys Ther (2014) 1.41
Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial. Mov Disord (2010) 1.34
Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res (2011) 1.29
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med (2011) 1.28
Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med (2008) 1.23
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging (2012) 1.19
Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Can J Psychiatry (2004) 1.15
Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord (2009) 1.15
Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. Drug Alcohol Depend (2008) 1.14
Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry (2009) 1.09
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain (2008) 1.08
Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol (2008) 1.06
Effect of duration of upper- and lower-extremity rehabilitation sessions and walking speed on recovery of interlimb coordination in hemiplegic gait. Phys Ther (2002) 1.05
Sensitivity to change and responsiveness of four balance measures for community-dwelling older adults. Phys Ther (2011) 1.05
Biomechanical mechanism for transitions in phase and frequency of arm and leg swing during walking. Biol Cybern (2004) 1.03
Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia. Mol Genet Metab (2006) 1.03
The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology (2002) 1.03
Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder. Biol Psychiatry (2004) 1.02
Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. J Neurol Neurosurg Psychiatry (2009) 0.99
The effects of auditory rhythms and instruction on walking patterns in individuals post stroke. Gait Posture (2006) 0.99
Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy. Neuropsychopharmacology (2008) 0.98
Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies. J Nucl Med (2013) 0.98
Somatostatin receptor scintigraphy in nasopharyngeal carcinoma. Clin Nucl Med (2008) 0.97
Co-occurrence of early-onset Parkinson disease and 22q11.2 deletion syndrome: Potential role for dopamine transporter imaging. Am J Med Genet A (2010) 0.97
A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology (2006) 0.96
The role of dopamine in human addiction: from reward to motivated attention. Eur J Pharmacol (2005) 0.96
Test-retest reliability of 24 hours of activity monitoring in individuals with Parkinson's disease in home and community. Neurorehabil Neural Repair (2007) 0.94
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging (2012) 0.93
Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender. Eur J Nucl Med Mol Imaging (2009) 0.93
Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) (2004) 0.93
Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry (2003) 0.93
Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. J Psychopharmacol (2006) 0.92
Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology (2005) 0.92
Increased musculoskeletal stiffness during load carriage at increasing walking speeds maintains constant vertical excursion of the body center of mass. J Biomech (2003) 0.92
Changes in walking activity and endurance following rehabilitation for people with Parkinson disease. Arch Phys Med Rehabil (2009) 0.91
Effects of optic flow speed and lateral flow asymmetry on locomotion in younger and older adults: a virtual reality study. J Gerontol B Psychol Sci Soc Sci (2009) 0.91
AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures. Eur J Nucl Med Mol Imaging (2008) 0.91
Monitoring activity in individuals with Parkinson disease: a validity study. J Neurol Phys Ther (2006) 0.91
Early and presenting symptoms of dementia with lewy bodies. Dement Geriatr Cogn Disord (2011) 0.91
Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2013) 0.90
Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. J Clin Psychiatry (2011) 0.90
Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology (Berl) (2011) 0.89
No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage (2012) 0.89
Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. Nucl Med Biol (2012) 0.88
Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor. Eur J Med Chem (2011) 0.88
Neurotoxic effects of ecstasy on the thalamus. Br J Psychiatry (2008) 0.88
Diet-induced changes in the Lean Brain: Hypercaloric high-fat-high-sugar snacking decreases serotonin transporters in the human hypothalamic region. Mol Metab (2013) 0.88
Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.86
Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse (2002) 0.86
Visuospatial perception and navigation in Parkinson's disease. Vision Res (2010) 0.86
Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease. Mov Disord (2014) 0.85
Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease. Neuroimage (2005) 0.85
Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. Brain Behav (2012) 0.85
Impulsivity in adult ADHD patients with and without cocaine dependence. Drug Alcohol Depend (2012) 0.85
Varenicline increases striatal dopamine D(2/3) receptor binding in rats. Addict Biol (2009) 0.85
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. Eur Neuropsychopharmacol (2009) 0.85
Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology. J Psychopharmacol (2011) 0.85
Disrupted dopaminergic neurotransmission in 22q11 deletion syndrome. Neuropsychopharmacology (2007) 0.84
Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J Psychopharmacol (2006) 0.84
Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder. Pharmacogenet Genomics (2009) 0.84
Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. Eur J Nucl Med Mol Imaging (2014) 0.84
Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity. Diabetologia (2014) 0.84
VECTor: a preclinical imaging system for simultaneous submillimeter SPECT and PET. J Nucl Med (2012) 0.84
The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods Psychiatr Res (2005) 0.83
Changes in axial stiffness of the trunk as a function of walking speed. J Biomech (2006) 0.83
In vivo [(123)I]CNS-1261 binding to D-serine-activated and MK801-blocked NMDA receptors: A storage phosphor imaging study in rats. Synapse (2009) 0.83
Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study. BMJ Open (2012) 0.83
Functional electrical stimulation changes dynamic resources in children with spastic cerebral palsy. Phys Ther (2006) 0.83
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Psychopharmacology (Berl) (2001) 0.83
Subjective experiences during dopamine depletion. Am J Psychiatry (2005) 0.83
Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus. EJNMMI Res (2013) 0.83
Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J Psychopharmacol (2006) 0.83
Phase manipulation and walking in stroke. J Neurol Phys Ther (2007) 0.82
Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine D₂/₃ receptors in their high-affinity state. J Med Chem (2014) 0.82
Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease. Eur J Nucl Med Mol Imaging (2005) 0.82
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging (2010) 0.82
(123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study. BMJ Open (2013) 0.82
Assessing the optimal time point for the measurement of extrastriatal serotonin transporter binding with 123I-FP-CIT SPECT in healthy, male subjects. J Nucl Med (2012) 0.82
No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT. EJNMMI Res (2013) 0.81
In vitro and ex vivo storage phosphor imaging of short-living radioisotopes. J Neurosci Methods (2007) 0.81
SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice. Eur J Nucl Med Mol Imaging (2008) 0.81
Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. Drug Alcohol Depend (2013) 0.81
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis. Eur Neuropsychopharmacol (2012) 0.80
Monitoring walking and cycling of middle-aged to older community dwellers using wireless wearable accelerometers. Conf Proc IEEE Eng Med Biol Soc (2012) 0.80
Synthesis and evaluation of iodinated TZTP-derivatives as potential radioligands for imaging of muscarinic M2 receptors with SPET. Nucl Med Biol (2004) 0.80
Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity. Obesity (Silver Spring) (2012) 0.80
No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity. Eur J Nucl Med Mol Imaging (2006) 0.80